Literature DB >> 26019270

Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs.

Ali A Abdul-Sater1, Andrea Majoros2, Courtney R Plumlee1, Stuart Perry3, Ai Di Gu1, Carolyn Lee1, Sujan Shresta3, Thomas Decker2, Christian Schindler1,4.   

Abstract

IFNs, which transduce pivotal signals through Stat1 and Stat2, effectively suppress the replication of Legionella pneumophila in primary murine macrophages. Although the ability of IFN-γ to impede L. pneumophila growth is fully dependent on Stat1, IFN-αβ unexpectedly suppresses L. pneumophila growth in both Stat1- and Stat2-deficient macrophages. New studies demonstrating that the robust response to IFN-αβ is lost in Stat1-Stat2 double-knockout macrophages suggest that Stat1 and Stat2 are functionally redundant in their ability to direct an innate response toward L. pneumophila. Because the ability of IFN-αβ to signal through Stat1-dependent complexes (i.e., Stat1-Stat1 and Stat1-Stat2 dimers) has been well characterized, the current studies focus on how Stat2 is able to direct a potent response to IFN-αβ in the absence of Stat1. These studies reveal that IFN-αβ is able to drive the formation of a Stat2 and IFN regulatory factor 9 complex that drives the expression of a subset of IFN-stimulated genes, but with substantially delayed kinetics. These observations raise the possibility that this pathway evolved in response to microbes that have devised strategies to subvert Stat1-dependent responses.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26019270      PMCID: PMC4617678          DOI: 10.4049/jimmunol.1401139

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Immune response in Stat2 knockout mice.

Authors:  C Park; S Li; E Cha; C Schindler
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

Review 2.  Constitutive type I interferon modulates homeostatic balance through tonic signaling.

Authors:  Daniel J Gough; Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone; David E Levy
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

3.  Pooled shRNA screenings: experimental approach.

Authors:  Ruth Rodriguez-Barrueco; Netonia Marshall; Jose M Silva
Journal:  Methods Mol Biol       Date:  2013

4.  Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling.

Authors:  Bumsuk Hahm; Matthew J Trifilo; Elina I Zuniga; Michael B A Oldstone
Journal:  Immunity       Date:  2005-02       Impact factor: 31.745

Review 5.  Protein tyrosine phosphatases as wardens of STAT signaling.

Authors:  Frank-D Böhmer; Karlheinz Friedrich
Journal:  JAKSTAT       Date:  2014-02-20

Review 6.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

7.  Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice.

Authors:  Sujan Shresta; Kristin L Sharar; Daniil M Prigozhin; Heidi M Snider; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

8.  STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.

Authors:  Stuart T Perry; Michael D Buck; Steven M Lada; Christian Schindler; Sujan Shresta
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

9.  Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon.

Authors:  Cyril X George; Sonali Das; Charles E Samuel
Journal:  Virology       Date:  2008-09-06       Impact factor: 3.616

Review 10.  Cellular microbiology and molecular ecology of Legionella-amoeba interaction.

Authors:  Ashley M Richards; Juanita E Von Dwingelo; Christopher T Price; Yousef Abu Kwaik
Journal:  Virulence       Date:  2013-03-27       Impact factor: 5.882

View more
  17 in total

Review 1.  Impact of host genetic polymorphisms on vaccine induced antibody response.

Authors:  Janina E Linnik; Adrian Egli
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

2.  Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes.

Authors:  Laura Marroqui; Reinaldo S Dos Santos; Anne Op de Beeck; Alexandra Coomans de Brachène; Lorella Marselli; Piero Marchetti; Decio L Eizirik
Journal:  Diabetologia       Date:  2017-01-06       Impact factor: 10.122

3.  Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.

Authors:  Wen Li; Markus J Hofer; Pattama Songkhunawej; So Ri Jung; Dale Hancock; Gareth Denyer; Iain L Campbell
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 4.  The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Aleš Goropevšek; Marija Holcar; Tadej Avčin
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

5.  Integrity of a HPV11 infection cell model and identification of (-)-Epigallocatechin-3-gallate as a potential HPV11 inhibitor.

Authors:  Yang Sun; Xinyu Li; Shasha Song; Yongfang Wang; Heng Gu
Journal:  Oncotarget       Date:  2016-06-14

6.  STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.

Authors:  Shota Yamauchi; Kenji Takeuchi; Kazuyasu Chihara; Chisato Honjoh; Yuji Kato; Hatsumi Yoshiki; Hak Hotta; Kiyonao Sada
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

Review 7.  Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses.

Authors:  Andrea Majoros; Ekaterini Platanitis; Elisabeth Kernbauer-Hölzl; Felix Rosebrock; Mathias Müller; Thomas Decker
Journal:  Front Immunol       Date:  2017-01-26       Impact factor: 7.561

8.  Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1.

Authors:  Andrea Majoros; Ekaterini Platanitis; Daniel Szappanos; HyeonJoo Cheon; Claus Vogl; Priyank Shukla; George R Stark; Veronika Sexl; Robert Schreiber; Christian Schindler; Mathias Müller; Thomas Decker
Journal:  EMBO Rep       Date:  2016-02-12       Impact factor: 8.807

9.  Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.

Authors:  Tina M Sali; Kara M Pryke; Jinu Abraham; Andrew Liu; Iris Archer; Rebecca Broeckel; Julia A Staverosky; Jessica L Smith; Ahmed Al-Shammari; Lisi Amsler; Kayla Sheridan; Aaron Nilsen; Daniel N Streblow; Victor R DeFilippis
Journal:  PLoS Pathog       Date:  2015-12-08       Impact factor: 6.823

10.  STAT2-directed pathogen responses.

Authors:  Hans Bluyssen
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.